Daily Derm Times: April 30, 2025
Expanding Topical Non-Steroidal Options in Atopic Dermatitis to Reduce Chronic Steroid Use
Optimizing Atopic Dermatitis Care With Emerging Topical Therapeutics
Q32 Bio’s Bempikibart Receives FDA Fast Track Designation for Alopecia Areata